Black Cohosh

Name: Black Cohosh
Brand: Integrative Therapeutics

BrandIntegrative Therapeutics→Botanical Tablet or Pill 7 ingredients 1 high-risk 1 caution DSLD #23555

Net contents: 60 Tablet(s)

Target: Adults and Children 4 years and above

DSLD entry: 2013-10-25

2 Ingredients (7)

IngredientGroupSafety

Black Cohosh (Cimicifuga racemosa) root and rhizome extractBlack CohoshHigh risk

CelluloseCellulose—

Modified CelluloseCellulose—

Magnesium StearateMagnesiumUse with Caution

Soy Lecithinlecithin—

PeppermintPeppermint—

Carnauba WaxCarnauba wax—

Ingredient amounts require the full DSLD label. View full label at NIH DSLD →

⛔ High-risk ingredient — documented serious harm

Black Cohosh 🇺🇸 🇦🇺 🇪🇺 — Hepatotoxicity cases including liver failure — limit 6 months [1]

⚠️ Use with caution — restricted in some markets

Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].

3 Safety cross-reference

Black Cohosh — High risk

⚠ HEPATOTOXICITY (rare but serious)

⚠ Limit to 6 months

Magnesium — Use with Caution

⚠ Diarrhea (especially oxide)

⚠ Accumulates in renal impairment

4 Label claims

• All Other

• Structure/Function

5 Data source

DSLD ID23555

Full labelView at NIH DSLD →

SourceOffice of Dietary Supplements, NIH

Market statusOn market

Entry date2013-10-25

6 More from Integrative Therapeutics

View Integrative Therapeutics Safety Scorecard → 87 products

BMR Complex Bromelain 2400 GDU Buffered Vitamin C Cal-Mag Max ChildEssence Clinical Nutrients Eye Formula

7 Cite this page

Vancouver

Pkhakadze G. Black Cohosh — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/black-cohosh-23555/

CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.

Analyzed by SupplementIndex

PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD

Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG